TIA
NVO

Tiemann Investment Advisors’s Novo Nordisk NVO Stock Holding History

Tiemann Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,500
Closed -$194K – 214
2025
Q3 		$194K Hold
3,500
– – 0.07% 206
2025
Q2 		$242K Hold
3,500
– – 0.1% 164
2025
Q1 		$243K Sell
3,500
-250
-7% -$20.6K 0.11% 159
2024
Q4 		$323K Hold
3,750
– – 0.14% 123
2024
Q3 		$447K Sell
3,750
-300
-7% -$40K 0.19% 102
2024
Q2 		$578K Hold
4,050
– – 0.26% 78
2024
Q1 		$520K Hold
4,050
– – 0.23% 92
2023
Q4 		$419K Hold
4,050
– – 0.2% 102
2023
Q3 		$368K Hold
4,050
– – 0.2% 109
2023
Q2 		$328K Hold
4,050
– – 0.17% 129
2023
Q1 		$322K Hold
4,050
– – 0.18% 128
2022
Q4 		$274K Hold
4,050
– – 0.16% 147
2022
Q3 		$202K Hold
4,050
– – 0.13% 171
2022
Q2 		$226K Hold
4,050
– – 0.12% 166
2022
Q1 		$225K Sell
4,050
-1,500
-27% -$77K 0.1% 186
2021
Q4 		$311K Hold
5,550
– – 0.13% 162
2021
Q3 		$266K Hold
5,550
– – 0.13% 164
2021
Q2 		$232K Buy
+5,550
New +$215K 0.11% 191
2016
Q4 		– Sell
-14,000
Closed -$291K – 165
2016
Q3 		$291K Hold
14,000
– – 0.27% 119
2016
Q2 		$376K Buy
14,000
+2,500
+22% +$68.6K 0.35% 92
2016
Q1 		$312K Hold
11,500
– – 0.31% 107
2015
Q4 		$334K Hold
11,500
– – 0.34% 91
2015
Q3 		$312K Buy
11,500
+800
+7% +$22.7K 0.34% 96
2015
Q2 		$293K Hold
10,700
– – 0.3% 111
2015
Q1 		$286K Buy
10,700
+600
+6% +$13.8K 0.3% 109
2014
Q4 		$214K Hold
10,100
– – 0.23% 132
2014
Q3 		$240K Buy
10,100
+200
+2% +$4.6K 0.27% 119
2014
Q2 		$229K Buy
9,900
+400
+4% +$8.83K 0.25% 126
2014
Q1 		$217K Buy
+9,500
New +$202K 0.24% 135

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tiemann Investment Advisors's NVO Position: Q4 2025 in Review

Tiemann Investment Advisors sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 3,500 shares — an estimated $194K sold.

Tiemann Investment Advisors first reported a position in NVO in Q1 2014 and held it in 29 quarters. The position peaked at $578K in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Tiemann Investment Advisors reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Tiemann Investment Advisors sold 3,500 Novo Nordisk shares in Q4 2025, an estimated $194K.
  • Tiemann Investment Advisors first reported a position in Novo Nordisk in Q1 2014 and held it in 29 quarters.
  • Tiemann Investment Advisors's Novo Nordisk position peaked at $578K in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Tiemann Investment Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.